NFKB1 and chronic obstructive pulmonary disease: Both MSCs and exosomes derived from them improved peribronchial and vascular inflammation, thereby reducing the thickening of the alveolar septum in COPD via reducing the production of zeta C kinase protein and NF-κB subunits of p50 and p65 subunits [82].